Integrated Diagnostics Holdings PLC (IDHC)

Currency in USD
0.70
-0.01(-1.41%)
Closed·
IDHC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.700.72
52 wk Range
0.310.73
Key Statistics
Bid/Ask
0.60 / 0.79
Prev. Close
0.71
Open
0.72
Day's Range
0.72-0.72
52 wk Range
0.31-0.73
Volume
11.19K
Average Volume (3m)
193.87K
1-Year Change
60.92%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDHC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.80
Upside
+14.04%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Integrated Diagnostics Holdings PLC Company Profile

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.

Integrated Diagnostics Holdings PLC Earnings Call Summary for Q3/2025

  • Integrated Diagnostics reported 41% revenue growth in Q3 2025, with a 10% rise in test volumes and 28% increase in average revenue per test, though stock fell 3.03% post-earnings.
  • Financial metrics showed strong performance with gross profit margin expanding to 43% from 38% in 2024, and EBITDA margin rising to 35% from 30%.
  • The company expanded its branch network with 103 new locations in Egypt, which contributes 84% of total revenue.
  • Management forecasts full-year revenue growth exceeding 35%, maintaining EBITDA margin above 30%, with $20 million planned for Saudi Arabia expansion from 2026-2030.
  • CEO Dr. Hend El Sherbini indicated margin sustainability contingent on currency stability, with Saudi operations expected to contribute 7% of group revenue within five years.
Last Updated: 2025-11-25, 09:04 a/m
Read Full Transcript

Compare IDHC to Peers and Sector

Metrics to compare
IDHC
Peers
Sector
Relationship
P/E Ratio
17.6x19.2x−0.6x
PEG Ratio
0.470.120.00
Price/Book
6.2x1.4x2.6x
Price / LTM Sales
2.9x1.2x3.2x
Upside (Analyst Target)
14.1%27.2%42.3%
Fair Value Upside
Unlock19.6%5.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.80
(+14.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.88%
Dividend Yield
2.43%
Industry Median 153.72%
Annualized payout
0.02
Paid annually
5-Years Growth
+2.54%
Growth Streak

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IDHC Income Statement

FAQ

What Is the Integrated Diagnostics (IDHC) Stock Price Today?

The Integrated Diagnostics stock price today is 0.70

What Stock Exchange Does Integrated Diagnostics Trade On?

Integrated Diagnostics is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Integrated Diagnostics?

The stock symbol for Integrated Diagnostics is "IDHC."

Does Integrated Diagnostics Pay Dividends? What’s The Current Dividend Yield?

The Integrated Diagnostics dividend yield is 2.43%.

What Is the Integrated Diagnostics Market Cap?

As of today, Integrated Diagnostics market cap is 406.93M.

What Is Integrated Diagnostics's Earnings Per Share (TTM)?

The Integrated Diagnostics EPS (TTM) is 1.88.

When Is the Next Integrated Diagnostics Earnings Date?

Integrated Diagnostics will release its next earnings report on Nov 14, 2025.

From a Technical Analysis Perspective, Is IDHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Integrated Diagnostics Stock Split?

Integrated Diagnostics has split 1 times.

How Many Employees Does Integrated Diagnostics Have?

Integrated Diagnostics has 6309 employees.

What is the current trading status of Integrated Diagnostics (IDHC)?

As of Dec 29, 2025, Integrated Diagnostics (IDHC) is trading at a price of 0.70, with a previous close of 0.71. The stock has fluctuated within a day range of 0.72 to 0.72, while its 52-week range spans from 0.31 to 0.73.

What Is Integrated Diagnostics (IDHC) Price Target According to Analysts?

The average 12-month price target for Integrated Diagnostics is USD0.7982563, with a high estimate of USD0.90239496 and a low estimate of USD0.69411765. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +14.04% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.